(Q57240014)

English

Epigenetic and genetic alterations ofAPCandCDH1genes in lobular breast cancer: Relationships with abnormal E-cadherin and catenin expression and microsatellite instability

article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Epigenetic and genetic alterations ofAPCandCDH1genes in lobular breast cancer: Relationships with abnormal E-cadherin and catenin expression and microsatellite instability (English)

0 references

cancer research

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

David Hardisson

object named as

David Hardisson

3

0 references

Gema Moreno-Bueno

object named as

Gema Moreno-Bueno

2

0 references

object named as

Manel Esteller

8

0 references

James G. Herman

6

object named as

James G. Herman

0 references

author name string

David Sarrió

1

0 references

Carolina Sánchez-Estévez

4

0 references

Mingzhou Guo

5

0 references

Carlos Gamallo

7

0 references

José Palacios

9

0 references

language of work or name

0 references

publication date

8 May 2003

0 references

International Journal of Cancer

0 references

106

0 references

2

0 references

208-215

0 references

Cadherin cell adhesion receptors as a morphogenetic regulator

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

E-cadherin-catenin cell-cell adhesion complex and human cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

The cadherin-catenin adhesion system in signaling and cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Linking colorectal cancer to Wnt signaling

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Wnt signaling in breast cancer: have we come full circle?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Differential involvement of the hypermethylator phenotype in hereditary and sporadic colorectal cancers with high-frequency microsatellite instability

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Abnormalities of the APC/beta-catenin pathway in endometrial cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Mapping Patterns of CpG Island Methylation in Normal and Neoplastic Cells Implicates Both Upstream and Downstream Regions inde Novo Methylation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Mutations of the human E-cadherin (CDH1) gene

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

E-cadherin germline mutations in familial gastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Low frequency of E-cadherin alterations in familial breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Single-nucleotide polymorphism in theE-cadherin gene promoter modifies the risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Association of the -160 C --> a promoter polymorphism of E-cadherin gene with gastric carcinoma risk

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Somatic mutations of the APC gene in primary breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinomain situ

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

DNA methylation and gastrointestinal malignancies: functional consequences and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.11197

21 January 2018

Identifiers

10.1002/IJC.11197

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57240014&oldid=1947789707"